Takeda Pharmaceutical Company, a Japan-based global pharmaceutical company, recently announced an agreement with BioSurfaces Inc., a small Massachusetts research company, to research the development of medical devices for the treatment of gastrointestinal (GI) diseases. According to the announcement, Takeda will contribute its GI expertise to the development of medical devices to be designed by BioSurfaces using BioSurface’s biomaterial nanotechnology.
Gilead Sciences, Inc. recently announced an agreement to acquire Kite Pharma, Inc. for $11.9 billion. According to the announcement, Kite Pharma focuses on cell therapy treatment for cancer, which involves the genetic engineering and reintroduction of a patient’s own cells to better identify and combat cancers.
UK-based Creo Medical recently announced the clearance of its Speedboat RS2 surgical endoscopic device for minimally invasive removal of lesions in the bowel.
The FDA, according to its website, currently supports eight consortia that provide advice and funding to help commercialize technologies for pediatric care. The FDA defines “pediatric” as encompassing devices used for patients who are 21 years of age or younger at the time of diagnosis or treatment.
Courts increasingly rely on analogies to show that claims are not directed to patent-eligible subject matter under 35 U.S.C. § 101. For example, in Context Extraction and Transmission v. Wells Fargo Bank, the Federal Circuit found that the claimed method of information processing was analogous to the way that “banks have, for some time, reviewed checks, recognized relevant data such as the amount, account number, and identity of account holder, and stored that information in their records.”
Wayne, Pennsylvania-based Teleflex Inc. announced it will purchase privately-held NeoTract Inc. for approximately $1.1 billion. According to the press release, Teleflex will pay NeoTract $725 million when the deal closes and an…
Basil Leaf Technologies recently presented their DxtER device at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego. The DxtER device has been compared to the Star Trek medical Tricorder, winning first place in the Qualcomm Tricorder Xprize competition, a global contest inspired by the popular science fiction series.
On August 11, 2017 a northern California federal court permanently enjoined Sealant Systems Int’l (SSI) from selling tire repair kits that infringed TEK Global’s patent.
On August 15, 2017, a federal court in Illinois resolved a damages and fees dispute in a patent infringement case that had raged for nearly eleven years. R-BOC Representatives, Inc. (R-BOC) and Dura-Line Corporation (Dura-Line) were both found to infringe Mr. Minemyer’s patent on plastic pipe couplers (designed to join to pieces of pipe), and both were permanently enjoined from selling infringing couplers.
On August 11, 2017, a Los Angeles jury found that Zazzle, Inc (“Zazzle”) owed Greg Young Publishing Inc. (“GYP”) $460,000 for copyright infringement—a fraction of the maximum statutory damages GYP could have received.
